ArticleJMIR research protocols2023

Efficacy and Safety of Mizoribine for the Treatment of Refractory Nephrotic Syndrome: Protocol for a Multicenter, Controlled, Open-label, Randomized Controlled Trial.

Zheyi Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.